Healthcare provider profile · identity verified

Ryan David Manns, MD

Family Practice · BEAVERTON, OR · NPI 1386007920

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	373	111
Lisinopril	Lisinopril	203	66
Losartan Potassium	Losartan Potassium	158	47
Amlodipine Besylate	Amlodipine Besylate	124	41
Gabapentin	Gabapentin	92	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	92	26
Simvastatin	Simvastatin	88	29
Albuterol Sulfate Hfa	Albuterol Sulfate	87	35
Metoprolol Tartrate	Metoprolol Tartrate	84	30
Levothyroxine Sodium	Levothyroxine Sodium	77	30
Metformin Hcl	Metformin Hcl	76	29
Pradaxa	Dabigatran Etexilate Mesylate	74	24
Oxycodone Hcl	Oxycodone Hcl	70	29
Ondansetron Odt	Ondansetron	67	17
Furosemide	Furosemide	64	19
Glipizide	Glipizide	62	20
Hydrochlorothiazide	Hydrochlorothiazide	62	23
Tamsulosin Hcl	Tamsulosin Hcl	60	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	57	24
Omeprazole	Omeprazole	57	16
Trazodone Hcl	Trazodone Hcl	57	25
Fluoxetine Hcl	Fluoxetine Hcl	56	16
Metformin Hcl Er	Metformin Hcl	55	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	53	11
Potassium Chloride	Potassium Chloride	50	16
Duloxetine Hcl	Duloxetine Hcl	47	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	47	24
Pravastatin Sodium	Pravastatin Sodium	43	13
Wixela Inhub	Fluticasone Propion/Salmeterol	36	suppressed
Pregabalin	Pregabalin	34	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	34	14
Alendronate Sodium	Alendronate Sodium	33	15
Allopurinol	Allopurinol	33	12
Buspirone Hcl	Buspirone Hcl	33	suppressed
Ozempic	Semaglutide	33	suppressed
Sertraline Hcl	Sertraline Hcl	33	14
Eliquis	Apixaban	32	suppressed
Propranolol Hcl	Propranolol Hcl	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Atenolol	Atenolol	31	11
Carvedilol	Carvedilol	26	suppressed
Finasteride	Finasteride	26	suppressed
Spiriva Respimat	Tiotropium Bromide	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	22	suppressed
Estradiol	Estradiol	22	suppressed
Metoprolol Succinate	Metoprolol Succinate	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	11
Prednisone	Prednisone	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	suppressed
Jardiance	Empagliflozin	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Humulin N	Insulin Nph Human Isophane	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	12
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Montelukast Sodium	Montelukast Sodium	16	suppressed
Torsemide	Torsemide	16	suppressed
Trospium Chloride	Trospium Chloride	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	15	15
Bupropion Xl	Bupropion Hcl	14	suppressed
Famotidine	Famotidine	14	suppressed
Naproxen	Naproxen	14	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	14	suppressed
Clonazepam	Clonazepam	13	suppressed
Clopidogrel	Clopidogrel Bisulfate	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Alvesco	Ciclesonide	11	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error